On September 22, 2025, the White House hosted a press conference addressing actions and recommendations to address autism, including referencing a supposed link between acetaminophen (Tylenol) usage during pregnancy and autism.  

Central Jersey Family Health Consortium stands by the guidance set forth by the American College of Obstetricians and Gynecologists and the Society for Maternal Fetal Medicine on Monday, September 22 and Tuesday, September 23, 2025, respectively regarding these recent announcements. 

There is little evidence that any medication use during pregnancy is 100% safe, however, the guiding question when it comes to evaluating medication use during pregnancy has always been, “Is the risk of [various illness] greater than the known risks of the drug and/or treatment?”  

There have been multiple studies and trials on the impact of acetaminophen use during pregnancy, including a study by Journal of the American Medical Association (JAMA) published in April 2024 that found no correlation between acetaminophen usage during any stage of pregnancy and Autism, ADHD and Intellectual Disabilities.  

Our mission is to promote an equitable and healthy future for children and families through advocacy, education and collaboration, and in doing so we enthusiastically support continued research to understand the potential causes of neurodevelopmental disabilities in children. 

Central Jersey Family Health Consortium is dedicated to ensuring its staff, community partners, and families remain confident in providing and seeking evidence-based care, and the trusted guidance of medical professionals.